NorthX Medical lists on Shanghai's STAR Market, advancing China's cardiovascular device innovation

prnasia.com (Chinese)

NorthX Medical, a leading Chinese innovator in cardiovascular medical devices, successfully listed on the STAR Market today. The company's IPO on the Shanghai Stock Exchange saw an opening price of 50.31 yuan per share, valuing it at 20.98 billion yuan. NorthX Medical is recognized for developing China's first domestic IVUS and FFR products, filling market gaps. Founded in 2015, NorthX Medical focuses on precise interventional solutions for cardiovascular diseases, aiming to reduce reliance on imported medical equipment.


With a significance score of 1.6, this news ranks in the top 30% of today's 28986 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


NorthX Medical lists on Shanghai's STAR Market, advancing China's cardiovascular device innovation | News Minimalist